From the Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University.
Plast Reconstr Surg. 2024 Oct 1;154(4):666e-672e. doi: 10.1097/PRS.0000000000010804. Epub 2023 Jun 12.
Follicular vitiligo is a distinct subtype of vitiligo characterized by the selective destruction of the follicular melanocytic reservoir. Treatment of follicular vitiligo-associated leukotrichia has always been a clinical challenge.
Twenty participants (mean age, 29 years) with stable follicular vitiligo were recruited between 2020 and 2021 for 2-stage surgery. In stage 1, an incision around the vitiligo lesion was performed to subcutaneously dissect and scrape the leukotrichia. In stage 2, healthy follicles obtained from the occipital donor site were transplanted into the vitiligo area. Follow-up examinations were conducted for 1 year postoperatively using a camera and dermatoscope to observe the growth rate, color, and surviving number of the transplanted hairs. Patient satisfaction was recorded to evaluate the potential surgical improvement.
The transplanted hair grew with natural texture, as expected. The average survival rate of the transplanted hair follicles was 93.8%. No recurrence of leukotrichia was observed in the recipient area. No complications were observed, and the postoperative scars in the recipient area were entirely covered by black hair. All patients were satisfied with their resulting appearance.
Minimally invasive removal of leukotrichia combined with hair transplantation might be an appropriate surgical option for stable follicular vitiligo to create natural and stable pigmented hair.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
滤泡性白癜风是一种独特的白癜风亚型,其特征是毛囊黑素细胞库的选择性破坏。治疗与滤泡性白癜风相关的白发一直是临床挑战。
2020 年至 2021 年间,招募了 20 名(平均年龄 29 岁)稳定期滤泡性白癜风患者进行两阶段手术。在第 1 阶段,围绕白癜风病变进行切口,以皮下解剖和刮除白发。在第 2 阶段,从枕部供体部位获取健康的毛囊移植到白癜风区域。术后 1 年通过相机和皮镜进行随访检查,观察移植毛发的生长速度、颜色和存活数量。记录患者满意度以评估潜在的手术改善情况。
移植的毛发如预期般自然生长。移植毛囊的平均存活率为 93.8%。受区未见白发复发。未观察到任何并发症,受区的术后疤痕完全被黑发覆盖。所有患者对术后外观均满意。
微创去除白发联合毛发移植可能是治疗稳定期滤泡性白癜风的一种合适的手术选择,可创造自然、稳定的色素性毛发。
临床问题/证据水平:治疗,IV。